glp-1 positive effects Semaglutide & Mental Health GLP-1 Agonists in Cardiovascular Diseases:

With up to 10 days of battery life, its the most low-maintenance fitness tracker Ive ever owned

[DOI] [PubMed] [Google Scholar] [49].Vora LK, Sabri AH, McKenna PE, Himawan A, Hutton AR, Detamornrat U, Paredes AJ, Larraeta E, Donnelly RF, Microneedle-based biosensing, Nature Reviews Bioengineering (2023) 118

"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026

While these drugs offer important treatments for obesity and diabetes, conditions that disproportionately impact Black Americans and underserved populations, their potential is undermined by systemic barriers that prioritize profits over public health